Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide (Q43290402)
Jump to navigation
Jump to search
scientific article published on 18 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide |
scientific article published on 18 August 2009 |
Statements
1 reference
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide (English)
1 reference
1 reference
Michael Weller
1 reference
Oystein Fluge
1 reference
Gregor Dresemann
1 reference
Mark A Rosenthal
1 reference
Ulrich Wedding
1 reference
Wolfgang Wagner
1 reference
Erik Engel
1 reference
Bernhard Heinrich
1 reference
Regine Mayer-Steinacker
1 reference
Anders Karup-Hansen
1 reference
Maximilian Mehdorn
1 reference
Eberhard Schleyer
1 reference
Dietmar Krex
1 reference
Ian N Olver
1 reference
Joachim P Steinbach
1 reference
Christian Hosius
1 reference
Christian Sieder
1 reference
Greg Sorenson
1 reference
Richard Parker
1 reference
Zariana Nikolova
1 reference
18 August 2009
1 reference
1 reference
96
1 reference
3
1 reference
393-402
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference